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The  major  receptors  for  antigen  on  murine  B  lymphocytes  are  currently 
thought to consist of monomeric IgM and an immunoglobulin  molecule previ- 
ously proposed to represent the murine homolog of human IgD (1-7).  Whether 
other classes of immunoglobulin function as receptors remains controversial (1, 
2). In particular, it now appears that very few human or murine B cells bear IgG 
on their surface (1-8). 
Studies of the murine  IgD-like molecule have been hindered  by the lack of 
specific antisera.  However, we have recently reported the presence of an allo- 
typic determinant on the murine IgD-like molecule and have shown that some 
commonly available alloantisera contain antibodies to this molecule. Since the 
IgD-like molecule was found to be structurally  and serologically distinct from 
the known serum immunoglobulins,  a  new immunoglobulin heavy chain gene 
(Ig-5) was proposed (7). The production of a specific antiserum to this molecule 
was also recently described by Abney et al., who immunized rabbits with IgD- 
like immunoglobulin purified from lymphocyte membranes by affinity chroma- 
tography (9). 
It has previously been reported that individual human leukemias bore identi- 
cal idiotypes on surface IgM and IgD  (10-12).  Raff et al.  (13) and Nossal and 
Layton (14) have shown that  all the  immunoglobulin  detected by polyspecific 
anti-immunoglobulin antisera on individual antigen-binding cells was able to be 
capped by antigen. Taken together, these results infer that an individual B cell 
is capable of the simultaneous expression of one variable region gene product 
attached to two different constant region gene products. 
In this paper, we report the direct demonstration that (a) most splenic B cells 
from mice aged 11-52 wk bear both  it- and 8-like heavy chains,  (b) splenic B 
cells from neonatal mice possess surface ~-chains only,  (c) when treated with 
specific antisera,  these molecules cap independently,  and  (d) the two receptor 
types on individual cells can be co-capped by antigen. 
Materials  and Methods 
Mice.  C57BL/6  and  its  allotype  congenic partner  strain  (7)  C57BL/6.Ig~'N14F4  were  from 
Walter and Eliza Hall Institute stocks. Mice of either sex were used. 
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Antigens and Antisera.  Antisera made in C57BL/6 mice against CBA/CaH WEHI spleen cells 
were produced and tested as previously described (7). The antisera used contained antibodies to H- 
2  k and Ia  k antigens and also to IgD-like surface immunoglobulin (7). When tested against C57BL/ 
6.Ig  ~ cells, only antibodies to IgD are detected (7).  Fluorescein (FITC)-conjugated anti-~-serum 
was purchased  from Meloy Laboratories Inc., Springfield, Va.,  and the heavy chain specificity 
confirmed  by  radioimmunoassay  by  Dr.  N.  L.  Warner.  Rabit  antiserum  to  mouse  IgG  was 
rendered specific for y-chains by repeated absorption with the 19S fraction of serum from old NZB 
mice coupled to Sepharose 4B. The IgG fraction of this serum (isolated by protein A-Sepharose) 
was conjugated  (15)  with tetramethyl  rhodamine  isothiocyanate  (TRITC, Baltimore Biological 
Laboratories, Cockeysville, Md.) using 10 ~g TRITC (dissolved in dimethyl sulfoxide) per mg IgG. 
Conjugates  were  purified  by  DEAE-Sephadex  A50  with  linear  salt  gradient  elution.  The 
OD555:OD28o ratio was 0.5, and the conjugate was used at 0.5 mg/ml. 
4-hydroxy-3-iodo-5-nitrophenylacetic acid coupled to polymerized flagellin (NIP-POL) was pro- 
duced as previously described (14). 
Enrichment of Antigen-Binding Cells.  The separation of antigen-specific B cells on hapten- 
ated gelatin adsorbents was as previously described (14). 
Fluorescence Procedures.  Treatment  of cells with  antisera,  washing,  and  examination  for 
fluorescence was as previously described (14). Typically 200 cells were counted per slide. 
Results and Discussion 
Lymphoid cells from  11-wk-old C57BL/6 or  C57BL/6.Ig  ~ mice were treated 
with  fluorescein-conjugated  goat  antiserum  to  mouse  ~-chain  (FITC-anti-~), 
washed,  and  then  held with C57BL/6 anti-CBA  spleen serum  Canti-8").  The 
cells were washed once again  and then treated  with tetramethyl  rhodamine- 
conjugated rabbit antiserum to mouse ~/-chains  (TRITC-anti-~/).  All manipula- 
tions were at 4°C. After a final wash cells were examined for fluorescence (Table 
I). 
In both control  (C57BL/6) and  experimental  (C57BL/6.Ig  ~) groups,  approxi- 
mately 43% of spleen cells showed green membrane fluorescence, indicating the 
presence of surface IgM.  When cells from C57BL/6.Ig  ~ mice were treated with 
FITC-anti-~,  followed by C57BL/6 anti-CBA and TRITC-anti~/,  a considerable 
fraction bore red membrane fluorescence (Table I), indicating the presence of 8- 
chains.  When C57BL/6 cells were examined for red fluorescence, only 1-2% of 
these control cells were positive, indicating that very few B cells bore detectable 
surface IgG. This result was consistent with previous biochemical and immuno- 
fluorescence studies (1, 2,  7, 8). 
Considerable attention was given to the specificity of staining, particularly to 
the problem of binding of complexes and aggregates to Fc receptors. The finding 
that significant numbers of red staining cells were only found when the target 
cells were of the appropriate Ig-5 allotype indicates that nonspecific staining due 
to binding to the Fc receptor did not occur. The anti-~-serum was also tested for 
binding  to  the  Fc  receptor  by  use  of the  T-cell  tumor  line  S-49.  This  line 
possesses a very strong Fc receptor, but does not possess enough surface immu- 
noglobulin  to  be  detected  by immunofluorescence  (16).  This  tumor  line  has 
proven very useful as a  sensitive reagent  for testing for the presence of IgG 
aggregates.  When  tested  against  S-49,  the  FITC-anti-~  serum  produced  no 
visible membrane  staining.  These controls, together with the previously pub- 
lished data (7),  indicate that staining was specific. 
Significant  numbers  of cells  positive  for  IgD-like  surface  immunoglobulin 
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TABLE  I 
Organ Survey of Surface Imrnunoglobulin  in 11-Wk-Old C57BL/6.Ig e Mice 
Percent  positive 
/~+8  ~+5 +*  #  8  +*  ~-8- 
Spleen  7.0  35.7  5.6  51.8 
Thymus  0.2  0.2  0.2  100 
Lymph node  2.2  17.6  2.2  78.0 
Peyer's patch  1.8  36.5  4.8  56.9 
Bone marrow  5.0  2.3  0.5  92.2 
Cells were treated with 1:15 (vol/vol)  dilution  of FITC-anti-v. for 30 min at 4°C, washed, and treated with 1:10 (vol/vol) dilution  of 
C57BL/6 anti CBA serum (4°C, 30 rain).  Cells were washed again and treated with TRITC-anti-7 (0.5 mg/ml final concentration) 
for 60 min at 4°C. After a final wash, cells were examined for fluorescence. At least 200 cells were counted (500 for thymus). 
Cells from control (C57BL/6) mice were treated in an identical fashion. The percentage of p.-poeitive cells was similar to that of 
C57BL/6.Ige, but only approximately 1% showed  red staining. 
* Figures include any ceils bearing ~-chaine. 
cells were found in bone marrow, but none in thymus. Most of the positive cells 
in all organs were also stained for surface IgM. Preliminary results of velocity 
sedimentation studies indicate that of the Ig-positive cells in the rapidly sedi- 
menting group, about half are "~ only" and the remainder are doubles, confirm- 
ing the suggestion of Goodman et al.  (17).  In bone marrow,  a  larger fraction 
(68%)  of positive  cells  bore  /~-chains  only,  although  significant  numbers  of 
doubles were also seen. 
There was considerable variation among cells in the intensity of staining with 
the anti-8-1ike serum.  A  similar observation was made by Abney et al.  (9).  It 
must therefore be stressed that the figures obtained will be influenced by the 
sensitivity  of the  method,  and  the  "cut  off' point  (fluorescence significantly 
above background)  is somewhat arbitrary.  Since the control values  (C57BL/6 
treated  with  C57BL/6  anti-CBA  followed  by  TRITC  anti-~/)  have  not  been 
subtracted, cells with red membrane fluorescence could have borne either y- or 
S-chains.  However, the number of v-bearing cells in C57BL/6 never exceeded 
2%, so it is reasonable to conclude that any significant excess over this number 
is due to S-bearing cells. 
When  a  similar  experiment  was  performed  with  9-day-old  mice,  approxi- 
mately 21% of spleen cells were positive for/~-chains, but only 1% were stained 
with C57BL/6 anti-CBA (Table II). However, a few S-positive cells were found in 
lymph node. All these cells were also positive for/~-chains.  Cells from 1-yr-old 
mice were also examined.  In spleen, 32% of all cells were/~+~+, 4% were/~-8 +, 
and 2% ~+8-,  and in lymph node the figures were very similar,  although/~+8- 
cells were scarce (1-2%). Peyer's patch cells from 1-yr-old mice were also mostly 
doubles,  although  the  intensity  of red fluorescence was  subjectively greater. 
Thoracic  duct cells from 24-wk-old mice contained  27%  ~+8 +,  2.1%  /~-8 +,  and 
<0.5%  /~+8- (less than 0.3% of 2,500 cells counted bore detectable ~/-chains  in 
control experiments).  These results confirm and extend those of Abney et al.  (9) 
and provide additional evidence for the specificity of staining. 
It has already been shown (18) that surface IgM and IgD cap independently on 
human lymphocytes. Similar results have been reported in the mouse (7, 9). As 
a control for the experiments to follow, an additional experiment was performed 
to demonstrate independent capping in the systems used in this study. Because 
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TABLE  II 
Organ Distribution of Surface Immunoglobulin in 9-Day-Old and 23-Day-Old 
C57BL/6 Jg  ~" Mice* 
855 
Percent positive 
9-day old 
Spleen  20 (17)  I (I)  0,2 (0.2)  79 (82) 
Thymus  0.I (0.I)  O.l (0.1)  0.1 (0.1)  I00 (100) 
Lymph node  7 (13)  5 (1)  0.1 (0.1)  38 (86) 
Bone marrow  3 (3)  0.1 (0.1)  0.1 (0.1)  97 (97) 
23-day old 
Spleen  21,5  12.0  0,5  66.5 
Thymus  0.1  0,1  0.1  1O0 
Lymph node  5.9  13.4  1.1  79.7 
Peyer's patch  5.6  30.0  0.6  64.4 
Bone marrow  3.8  0.2  0,2  96 
At least  200 cells  were counted. In the case of  thymus, approximately 1,00O  cells  were scanned and no positiveicells  were,seen. 
Staining protocol  as for Table L 
* Control C57BL/6 values are in parentheses. 
Figures include any cells  bearing T-chains. 
TABLE  III 
Independent Capping of Surface IgM and IgD-Like 
Immunogtobulin 
g-caps, ~-ringa  Both chains capped  8-caps only 
76%  2.9%  21% 
Spleen cells  from C57BL/6. Ig  ~  mice (aged 17 wk) were fractionated  on NIP-gelatin as  previously 
described; 51% were shown to bind detectable amounts of  TRITC-NIP-POL.  Calls were treated 
with C57BL/6 anti-CBA serum (1:10  vol/vol)  for  30 min at room temperature,  washed, and held 
with TRITC-anti-7  (0.5  mg/ml) in an identical  fashion. All media and reagents following this 
step contained 10 mM  sodium aside.  Cells  were washed and resuspended in  FITC-anti-p, held  at 
4°C for  30 min, washed, and examined. 100 cells  with red caps were examined for  distribution  of 
green fluorescence. 
addition  of reactants was reversed from the previous experiments (legend  to 
Table III).  The 8-1ike  receptors  were capped by treatment with C57BL/6 anti- 
CBA serum followed  by  TRITC-anti-T. After  the  second layer,  cells  were  washed 
in medium containing 10 mM  sodium azide  to prevent further capping. All 
subsequent washes and incubations  were in  medium containing 10  mM  sodium 
azide.  Cells  were  treated  with  FITC-anti-/~  and  were  washed and  examined after 
30  rain  at  4°C.  Control experiments showed that  10  mM  sodium azide  prevented 
capping.  The great  majority  of  cells  (Table  Ill)  showed  red  caps  with  green  rings, 
confirming the previous findings. 
To  test  whether  the ft-  and  a-like  chains had similar  antigen-binding  specific- 
ity, spleen  cells  from 12-wk-old  C57BL/61g  ~ mice were fractionated  on NIP- 
gelatin dishes  as previously described (14).  Their receptors  were capped by 
treatment  with  30 ~g/ml of  NIP-POL (30  rain  at  4°C followed  by 5 rain  at  37°C), 
and cells  were then fixed with 1% paraformaldehyde (15 rain  at 4°C).  This 
protocol  has previously  been shown to prevent further  capping (14).  The cells 
were then  treated  with  FITC-anti-ft  followed  by C57BL/6 anti-CBA and  TRITC- 
anti-  T (conditions  as for Table I). The fractionated  cells  contained 41% which 
bound detectable amounts of TRITC-conjugated NIP-POL as previously de- 
scribed  (14).  Cells  were examined for  the  presence  of  green  caps.  Of  50  cells  with 856  GODING  AND  LAYTON  BRIEF  DEFINITIVE  REPORT 
green (~) caps, 49 showed corresponding red caps and one was negative for red 
fluorescence. In a second experiment, all of 50 cells with green caps also had red 
caps. No cells were found with red caps that did not also have green caps. In a 
third experiment, NIP-specific cells from mice aged 17  wk were treated with 
NIP-POL  under  capping  conditions,  then  labeled  with  C57BL/6  anti-CBA, 
TRITC-anti-  T,  and FITC-anti-t~. All steps after antigen-induced capping were 
carried out in 10 mM sodium azide. Of the cells with red caps, 96% had green 
caps. 3% had red caps but a residual green ring, and 1% were negative for t~ (a 
lower percentage than in previous experiments). 
Our results show that most B cells from mice aged 11-52 wk bear beth IgM 
and IgD-like surface immunoglobulin. The finding that both receptors on indi- 
vidual cells can be capped by the same antigen indicated that both immunoglob- 
ulin classes have combining sites which recognize this antigen. 
Certain  human  lymphatic leukemias  have  been  shown  to  bear  identical 
idiotypes on surface IgM and IgD (10-12),  and a biclonal myeloma was recently 
found to possess identical variable region sequences on T- and  a-chains (19). 
Thus, the concept may be proposed that a  given lymphocyte is capable of the 
simultaneous expression of one variable region gene product attached to two 
different constant region gene products. This notion would be compatible with 
the idea that B cells are capable of an IgM to IgG "switch." 
Summary 
Double fluorescence studies indicated that most mature lymphocytes of 11-52- 
wk-old mice possess  both IgM and IgD-like surface immunoglobulins, while 
spleen cells from neonatal mice possess surface IgM only. These molecules cap 
independently with class-specific antisera, but co-cap when capping is induced 
by antigen. It is proposed that the two heavy chains on individual lymphocytes 
possess similar or identical antigen-combining sites. 
Received for publication 1 June 1976. 
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